Cargando…

A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics

AIM: This study is aimed at developing a novel admixture-adjusted pharmacogenomic approach to individually refine warfarin dosing in Caribbean Hispanic patients. PATIENTS & METHODS: A multiple linear regression analysis of effective warfarin doses versus relevant genotypes, admixture, clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duconge, Jorge, Ramos, Alga S., Claudio-Campos, Karla, Rivera-Miranda, Giselle, Bermúdez-Bosch, Luis, Renta, Jessicca Y., Cadilla, Carmen L., Cruz, Iadelisse, Feliu, Juan F., Vergara, Cunegundo, Ruaño, Gualberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706412/ https://www.ncbi.nlm.nih.gov/pubmed/26745506 http://dx.doi.org/10.1371/journal.pone.0145480

Ejemplares similares

Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study
por: Claudio-Campos, Karla, et al.
Publicado: (2017)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
por: Roche-Lima, Abiel, et al.
Publicado: (2020)

Discovery of Ancestry-specific Variants Associated with Clopidogrel Response among Caribbean Hispanics
por: Yang, Guang, et al.
Publicado: (2023)

Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population
por: Hernandez-Suarez, Dagmar F, et al.
Publicado: (2018)

Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach
por: Duconge, Jorge, et al.
Publicado: (2021)

Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial
por: Hernandez-Suarez, Dagmar F, et al.
Publicado: (2020)

2042 CYP2C19*2 and PON1 Q192R polymorphisms are associated with platelet reactivity to clopidogrel in Puerto Rican Hispanics with cardiovascular disease
por: Suarez, Dagmar F. H., et al.
Publicado: (2018)

2220: Pharmacogenomic determinants in Caribbean Hispanics of clopidogrel failure in acute coronary syndrome
por: Melin, Kyle, et al.
Publicado: (2018)

Expression Profiling Identifies TWIST2 Target Genes in Setleis Syndrome Patient Fibroblast and Lymphoblast Cells †
por: Crespo, Noe E., et al.
Publicado: (2021)

Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient: Role of a Novel NQO1*2 Polymorphism
por: Hernandez-Suarez, Dagmar F., et al.
Publicado: (2016)

2529: Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Caribbean Hispanics
por: Suarez, Dagmar Fredy Hernandez, et al.
Publicado: (2018)

The Identification of Admixture Patterns Could Refine Pharmacogenetic Counseling: Analysis of a Population-Based Sample in Mexico
por: Martínez-Magaña, José Jaime, et al.
Publicado: (2020)

Admixture Mapping of Alzheimer’s disease in Caribbean Hispanics identifies a new locus on 22q13.1
por: Kizil, Caghan, et al.
Publicado: (2022)

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)

Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009)

[Hispanic Caribbean litarature]
por: González, Echeverría Roberto
Publicado: (1980)

331 A Machine Learning-based Pharmacogenomic Association Study of Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic Patients on Clopidogrel
por: Arroyo, Luis A. Rosario, et al.
Publicado: (2022)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Admixture in Hispanic-Americans: Its impact on ITGAM association and implications for admixture mapping in SLE
por: Molineros, Julio E., et al.
Publicado: (2009)

Warfarin pharmacogenetics: How close are we to clinical practice?
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Warfarin Dosage Response Related Pharmacogenetics in Chinese Population
por: Li, Siyue, et al.
Publicado: (2015)

Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer’s disease in Caribbean Hispanics
por: Horimoto, Andréa R. V. R., et al.
Publicado: (2021)

Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
por: Liu, Rong, et al.
Publicado: (2015)

Skeletal Microstructure in Caribbean Hispanic Women
por: Agarwal, Sanchita, et al.
Publicado: (2023)

A Proposal for an Individualized Pharmacogenetic-Guided Warfarin Dosage Regimen for Puerto Rican Patients Commencing Anticoagulation Therapy
por: Bosch, Luis Ángel Bermúdez
Publicado: (2014)

The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort
por: Al Ammari, Maha, et al.
Publicado: (2020)

Insight on the Genetics of Atrial Fibrillation in Puerto Rican Hispanics
por: Gonzalez-Cordero, Ariel F., et al.
Publicado: (2021)

Genetic admixture and cardiovascular disease risk in postmenopausal Hispanic women()
por: Zuercher, Monica D., et al.
Publicado: (2022)

4423 Impact of Gender on High On-Treatment Platelet Reactivity (HPR) and Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic patients using Clopidogrel
por: Nunez Medina, Hector Jose, et al.
Publicado: (2020)

Hispanic culture of Mexico, Central America, and the Caribbean /
Publicado: (1996)

Personalized health and the coronavirus vaccines—Do individual genetics matter?
por: Valdés‐Fernández, Bianca N., et al.
Publicado: (2021)

Relationship between Adiposity and Admixture in African American and Hispanic American Women
por: Nassir, Rami, et al.
Publicado: (2011)

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients
por: Galvez, Jubby Marcela, et al.
Publicado: (2018)

Refining models of archaic admixture in Eurasia with ArchaicSeeker 2.0
por: Yuan, Kai, et al.
Publicado: (2021)

Non-Random Enrichment of Single-Nucleotide Polymorphisms Associated with Clopidogrel Resistance within Risk Loci Linked to the Severity of Underlying Cardiovascular Diseases: The Role of Admixture
por: Monero-Paredes, Mariangeli, et al.
Publicado: (2023)

Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2009)

Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model
por: Mazzaccara, Cristina, et al.
Publicado: (2013)

Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm
por: Pei, Lin, et al.
Publicado: (2018)

Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina
por: Ašić, Adna, et al.
Publicado: (2019)

Disease-related mutations among Caribbean Hispanics with familial dementia
por: Lee, Joseph H, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_erps65bjjbar28r8ivi7tjcs8u